Skip to main content
  • Contact Us
  • Subscriber Sign In
Evaluate Logo

navigation

  • What We Do
    • Commercial Intelligence
    • Products
      • Evaluate Pharma
      • Evaluate Omnium
      • Evaluate Medtech
      • Evaluate Epi
      • Japan Drug Forecasts
      • Europe Drug Forecasts
      • CDMO Intelligence
    • Pharma Consulting & Analytics
      • Pharma Consulting & Analytics
      • Data Feeds
    • Evaluate Vantage
      • News
      • Analysis
      • Policy & Pricing
      • Insights
      • Events
      • Medtech
      • Therapy Areas
    • Evaluate for Biotech
  • How We Can Help You
    • Pharma and Biotech
    • Financial Services
    • Management Consultancies
    • Service Providers
    • Customer Testimonials
  • Thought Leadership
    • Multimedia
    • Blog
  • About Us
    • Press Releases
    • Media Coverage
    • Executive Team
    • Vision & History
  • Contact Us
  • Sign Up for Evaluate Vantage
  • Talent
  • Subscriber Sign In

 

Vantage logo

Vantage

  • News
    • Snippets
    • Deals
    • Trial results
    • Patents and litigation
    • Corporate strategy
  • Analysis
    • Interviews
    • Spotlight
    • Vantage points
    • Vantage views
  • Insights
    • M&A
    • IPO
    • NME approvals
    • Quarterly shareprice performance
    • Venture financing
    • Vantage data points
    • Other data
  • Events
    • Company events
    • Conferences
    • Upcoming events
  • Medtech
  • Therapy Areas

Breadcrumb

  1. Home
  2. Vantage
  3. Pharmaceutical Companies
  4. Senseonics

Evaluate

Thumbnail
July 15, 2022

Despair engulfs smaller device companies

The nightmare on the public markets is not confined to the bigger groups.

Thumbnail
January 11, 2022

Diabetes device makers lead the smaller medtechs

Insulin pumps and glucose sensors flew off the shelves, whereas liquid biopsy developers both soared and sank.

Article image
Vantage logo
August 11, 2020

Ascensia throws Senseonics a lifeline

Article image
Vantage logo
October 17, 2019

Mixed diabetes blessings for Abbott

Article image
Vantage logo
August 22, 2019

The extremes converge in big medtech’s hiring practices

Intuitive Surgical makes the most money per employee – but the title of “most improved” goes to Philips.

Article image
Vantage logo
August 24, 2018

Typezero takeover puts Dexcom closer to an artificial pancreas

Dexcom can capitalise on its new algorithm technology, but is now enmeshed in a tangled web of partnerships.

Article image
Vantage logo
July 18, 2018

Despite the FDA’s best efforts, device approvals crash

Regulatory intervention having limited impact on fostering innovation.

Article image
Vantage logo
June 22, 2018

Tandem comes out the winner of the diabetes device approvals

Battle of the algorithms.

Article image
Vantage logo
June 21, 2018

Beta Bionics brings machine learning to insulin delivery

Can a device control a patient’s blood sugar based on bodyweight alone?

Article image
Vantage logo
March 13, 2018

FDA panel to make sense of implanted glucose meter

Senseonics best-in-class claims to be tested when blood glucose monitor goes before regulator.

Vantage logo
May 15, 2017

Artificial pancreas partnerships aim to compete with Medtronic

  • Load More

Latest Reports

July 27, 2023

H1 Round Up: The haves and the have-nots

July 21, 2023

ADA/EASL eBook

View more...

Editor's Picks

Vantage logo
July 03, 2023

Astrazeneca and Daiichi’s big reveal disappoints

Vantage logo
July 13, 2023

Pharma finds a way to gain weight

Vantage logo
July 03, 2023

Protagonist investors flake as psoriasis pill disappoints

Vantage logo
June 29, 2023

Approaching datasets for big pharma

Vantage logo
June 27, 2023

Nkarta goes back to basics

Open modal

Evaluate Logo

Evaluate HQ
44-(0)20-7377-0800

Evaluate Americas
+1-617-573-9450

Evaluate APAC
+81-80-1164-4754

Footer menu

  • Terms and conditions
  • Privacy Policies
  • Cookie Policy
  • Modern Slavery Statement

© Copyright 2023 Evaluate Ltd.

Sign up